Ross V. Weatherman - Related publications

Affiliations: 
Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Area:
Pharmacology, Pharmaceutical Chemistry, Biochemistry
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Rasmussen M, Tan S, Somisetty VS, Hutin D, Olafsen NE, Moen A, Anonsen JH, Grant DM, Matthews J. PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells. Cells. 10. PMID 33799807 DOI: 10.3390/cells10030623   
2021 Sellami A, Montes M, Lagarde N. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods. International Journal of Molecular Sciences. 22. PMID 33799614 DOI: 10.3390/ijms22062846   
2021 Ge J, Chen Y, Yang H, Zhao J, Ren D, Wu X. Expression and significance of estrogen receptor and progesterone receptor in endometrial tissue of patients with intrauterine adhesions. Gland Surgery. 10: 1478-1486. PMID 33968699 DOI: 10.21037/gs-21-232   
2021 He S, Li X, Ma JZ, Yang Y, Luo S, Xie XD, Yan BH, Yang J, Luo L, Cao LY. The potential endocrine disruption mechanism of anthelmintic drug niclosamide by activating estrogen receptors and estrogen-related receptors. Toxicology. 152805. PMID 33961950 DOI: 10.1016/j.tox.2021.152805   
2021 Tan J, Song C, Wang D, Hu Y, Liu D, Ma D, Gao Q. Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer. Bioscience Reports. PMID 33891016 DOI: 10.1042/BSR20210478   
2021 Lim I, Christiansen C, Chess-Williams R. 17β-estradiol and ureteral contractility: A role for the G protein-coupled estrogen receptor. European Journal of Pharmacology. 174024. PMID 33741380 DOI: 10.1016/j.ejphar.2021.174024   
2021 Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar C, Rui H, Yee D, Lange C. Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. Endocrinology. PMID 33735382 DOI: 10.1210/endocr/bqab060   
2021 Bansal S, Chopra K. Selective ER-β agonists alleviate neuronal deficits in insulin-resistant estrogen-deficient rats. Climacteric : the Journal of the International Menopause Society. 1-12. PMID 33719783 DOI: 10.1080/13697137.2020.1857353   
2021 Sixto-López Y, Marhuenda E, García-Vazquez JB, Fragoso-Vazquez MJ, Rosales-Hernández MC, Zacarías-Lara O, Méndez-Luna D, Gómez-Vidal JA, Cornu D, Norbert B, Correa-Basurto J. Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells. Cellular and Molecular Neurobiology. PMID 33740172 DOI: 10.1007/s10571-021-01072-9   
2021 Sato Y, Shigeta K, Hirasawa T, Sato T, Ogura J, Maekawa M, Ebata A, Hamanaka Y, Tada H, Ishida T, Kikuchi M, Mano N. Establishment of an analytical method for simultaneous quantitation of CDK4/6 inhibitors, aromatase inhibitors, and an estrogen receptor antagonist in human plasma using LC-ESI-MS/MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1173: 122655. PMID 33831689 DOI: 10.1016/j.jchromb.2021.122655   
2021 Houck KA, Patlewicz G, Richard A, Williams AJ, Shobair MA, Smeltz M, Clifton MS, Wetmore B, Medvedev A, Makarov S. Bioactivity Profiling of Per- and Polyfluoroalkyl Substances (PFAS) Identifies Potential Toxicity Pathways Related to Molecular Structure. Toxicology. 152789. PMID 33887376 DOI: 10.1016/j.tox.2021.152789   
2021 Moche H, Chentouf A, Neves S, Corpart JM, Nesslany F. Comparison of Endocrine Activity of Phthalates and Alternative Plasticizers. Journal of Toxicology. 2021: 8815202. PMID 33628236 DOI: 10.1155/2021/8815202   
2021 Choi JH, Choi SM, Lee SW, Jeh SU, Hyun JS, Lee MH, Lee C, Kam SC, Kim DC, Lee JS, Hwa JS. Expression Patterns of ERα, ERβ, AR, SIRT1, SIRT2, and SIRT3 in Prostate Cancer Tissue and Normal Prostate Tissue. Anticancer Research. 41: 1377-1386. PMID 33788729 DOI: 10.21873/anticanres.14895   
2021 Barroso A, Mahler JV, Fonseca-Castro PH, Quintana FJ. The aryl hydrocarbon receptor and the gut-brain axis. Cellular & Molecular Immunology. 18: 259-268. PMID 33408340 DOI: 10.1038/s41423-020-00585-5   
2021 Chen Q, Qi X, Fu Y, Ji T, Chao Y, Li J, Meng Q, Bian H, Li Y. Liuwei Dihuang formula protect endothelial cells from apoptosis by up-regulating expression of estrogen receptor-α. Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan. 41: 227-235. PMID 33825402   
2021 Radaeva M, Ban F, Zhang F, LeBlanc E, Lallous N, Rennie PS, Gleave ME, Cherkasov A. Development of Novel Inhibitors Targeting the D-Box of the DNA Binding Domain of Androgen Receptor. International Journal of Molecular Sciences. 22. PMID 33801338 DOI: 10.3390/ijms22052493   
2021 Schaefer IM, Lundberg MZ, Demicco EG, Przybyl J, Matusiak M, Chibon F, Ingram DR, Hornick JL, Wang WL, Bauer S, Baker LH, Lazar AJ, van de Rijn M, Mariño-Enríquez A, Fletcher JA. Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas. Cancer. PMID 33788262 DOI: 10.1002/cncr.33542   
2021 Patsch K, Liu C, Zapotoczny G, Sun Y, Sura H, Ung N, Sun RX, Haliday B, Yu C, Aljehani M, Lee JSH, Kashemirov BA, Agus DB, McKenna CE, Ruderman D. Paradoxical androgen receptor regulation by small molecule enantiomers. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33741738 DOI: 10.1073/pnas.2100918118   
2021 Shivnaraine RV, Kelly B, Elmslie G, Huang XP, Dong YJ, Seidenberg M, Wells JW, Ellis J. Allostery of atypical modulators at oligomeric G protein-coupled receptors. Scientific Reports. 11: 9265. PMID 33927236 DOI: 10.1038/s41598-021-88399-x   
2021 Gohda K, Iguchi Y, Masuda A, Fujimori K, Yamashita Y, Teno N. Design and identification of a new farnesoid X receptor (FXR) partial agonist by computational structure-activity relationship analysis: Ligand-induced H8 helix fluctuation in the ligand-binding domain of FXR may lead to partial agonism. Bioorganic & Medicinal Chemistry Letters. 41: 128026. PMID 33839252 DOI: 10.1016/j.bmcl.2021.128026   
2021 Deganutti G, Barkan K, Ladds G, Reynolds CA. Multisite Model of Allosterism for the Adenosine A1 Receptor. Journal of Chemical Information and Modeling. PMID 33779168 DOI: 10.1021/acs.jcim.0c01331   
2021 Lin B, Wang Q, Liu K, Dong X, Zhu M, Li M. Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer. Frontiers in Oncology. 11: 625936. PMID 33718192 DOI: 10.3389/fonc.2021.625936   
2021 Amelia T, van Veldhoven JPD, Falsini M, Liu R, Heitman LH, van Westen GJP, Segala E, Verdon G, Cheng RKY, Cooke RM, van der Es D, IJzerman AP. Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A Receptor. Journal of Medicinal Chemistry. PMID 33764785 DOI: 10.1021/acs.jmedchem.0c01856   
2021 Al Abri S, Al Rawahi A, Rao L. Elastosis in Breast Cancer as a Surrogate Marker for Estrogen Receptor Positivity. Oman Medical Journal. 36: e247. PMID 33898059 DOI: 10.5001/omj.2021.60   
2021 Fu L, Zhang H, Machuki JO, Zhang T, Han L, Sang L, Wu L, Zhao Z, Turley MJ, Hu X, Hou H, Li D, Harding SE, Sun H. GPER mediates estrogen cardioprotection against epinephrine-induced stress. The Journal of Endocrinology. PMID 33847279 DOI: 10.1530/JOE-20-0451   
2021 Zhou J, Wang Y, Wu D, Wang S, Chen Z, Xiang S, Chan FL. Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer. Oncogene. PMID 33750894 DOI: 10.1038/s41388-021-01737-1   
2021 Thirunavukkarasu MK, Shin WH, Karuppasamy R. Exploring safe and potent bioactives for the treatment of non-small cell lung cancer. 3 Biotech. 11: 241. PMID 33968584 DOI: 10.1007/s13205-021-02797-6   
2021 Kopp N, Civenni G, Marson D, Laurini E, Pricl S, Catapano CV, Humpf HU, Almansa C, Nieto FR, Schepmann D, Wünsch B. Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ receptor affinity, antitumor and analgesic activity. European Journal of Medicinal Chemistry. 219: 113443. PMID 33901806 DOI: 10.1016/j.ejmech.2021.113443   
2021 Liao C, Remington JM, May V, Li J. Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP. Frontiers in Molecular Biosciences. 8: 644644. PMID 33842547 DOI: 10.3389/fmolb.2021.644644   
2021 Wang M, Hou S, Wei Y, Li D, Lin J. Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking. Plos Computational Biology. 17: e1008821. PMID 33739970 DOI: 10.1371/journal.pcbi.1008821   
2021 Beinsteiner B, Markov GV, Erb S, Chebaro Y, McEwen AG, Cianférani S, Laudet V, Moras D, Billas IML. A structural signature motif enlightens the origin and diversification of nuclear receptors. Plos Genetics. 17: e1009492. PMID 33882063 DOI: 10.1371/journal.pgen.1009492   
2021 Okamoto Y, Shikano S. Tyrosine sulfation and O-glycosylation of chemoattractant receptor GPR15 differentially regulate interaction with GPR15L. Journal of Cell Science. PMID 33758080 DOI: 10.1242/jcs.247833   
2021 Hanneken A, Mercado M, Maher P. Constitutive and Regulated Shedding of Soluble FGF Receptors Releases Biologically Active Inhibitors of FGF-2. International Journal of Molecular Sciences. 22. PMID 33800200 DOI: 10.3390/ijms22052712   
2021 Schierle S, Chaikuad A, Lillich FF, Ni X, Woltersdorf S, Schallmayer E, Renelt B, Ronchetti R, Knapp S, Proschak E, Merk D. Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics. Journal of Medicinal Chemistry. PMID 33793232 DOI: 10.1021/acs.jmedchem.1c00235   
2021 Mason EO, Goldgur Y, Robev D, Freywald A, Nikolov DB, Himanen JP. Structure of the EphB6 receptor ectodomain. Plos One. 16: e0247335. PMID 33770085 DOI: 10.1371/journal.pone.0247335   
2021 Kroon J, Viho EMG, Gentenaar M, Koorneef LL, van Kooten C, Rensen PCN, Kooijman S, Hunt H, Meijer OC. The development of novel glucocorticoid receptor antagonists: From rational chemical design to therapeutic efficacy in metabolic disease models. Pharmacological Research. 168: 105588. PMID 33798733 DOI: 10.1016/j.phrs.2021.105588   
2021 Asiedu SO, Kwofie SK, Broni E, Wilson MD. Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm. Biomolecules. 11. PMID 33946644 DOI: 10.3390/biom11050653   
2021 Linossi EM, Estevam GO, Oshima M, Fraser JS, Collisson EA, Jura N. State of the structure address on MET receptor activation by HGF. Biochemical Society Transactions. PMID 33860789 DOI: 10.1042/BST20200394   
2021 Gaikwad S, González CM, Vilariño D, Lasanta G, Villaverde C, Mouriño A, Verlinden L, Verstuyf A, Peluso-Iltis C, Rochel N, Berkowska K, Marcinkowska E. Lithocholic acid-based design of noncalcemic vitamin D receptor agonists. Bioorganic Chemistry. 111: 104878. PMID 33853023 DOI: 10.1016/j.bioorg.2021.104878   
2021 Yokoi T, Nabe T, Horoiwa S, Hayashi K, Ito-Harashima S, Yagi T, Nakagawa Y, Miyagawa H. Virtual screening identifies a novel piperazine-based insect juvenile hormone agonist. Journal of Pesticide Science. 46: 68-74. PMID 33746548 DOI: 10.1584/jpestics.D20-074   
2021 Mohr F, Hurrle T, Burggraaff L, Langer L, Bemelmans MP, Knab M, Nieger M, van Westen GJP, Heitman LH, Bräse S. Synthesis and SAR evaluation of coumarin derivatives as potent cannabinoid receptor agonists. European Journal of Medicinal Chemistry. 220: 113354. PMID 33915369 DOI: 10.1016/j.ejmech.2021.113354   
2021 Mingle D, Ospanov M, Radwan MO, Ashpole N, Otsuka M, Ross SA, Walker L, Shilabin AG, Ibrahim MA. First In Class (,)-11-[2-(Arylmethylene)Hydrazono]-PBD Analogs As Selective CB2 Modulators Targeting Neurodegenerative Disorders. Medicinal Chemistry Research : An International Journal For Rapid Communications On Design and Mechanisms of Action of Biologically Active Agents. 30: 98-108. PMID 33776384 DOI: 10.1007/s00044-020-02640-2   
2021 Ding X, Zhao Z, Wu Y, Zhang H, Chen K, Luo C, Luo X, Xu H. Identification of novel anti-inflammatory Nur77 modulators by virtual screening. Bioorganic Chemistry. 112: 104912. PMID 33933804 DOI: 10.1016/j.bioorg.2021.104912   
2021 Fletcher MM, Keov P, Truong TT, Mennen G, Hick CA, Zhao P, Furness SGB, Kruse T, Clausen TR, Wootten D, Sexton PM. . The Journal of Pharmacology and Experimental Therapeutics. PMID 33727283 DOI: 10.1124/jpet.121.000567   
2021 Fang S, Livergood MC, Nakagawa P, Wu J, Sigmund CD. Role of the Peroxisome Proliferator Activated Receptors in Hypertension. Circulation Research. 128: 1021-1039. PMID 33793338 DOI: 10.1161/CIRCRESAHA.120.318062   
2021 Chowrasia D, Jafri A, Azad I, Rais J, Sharma N, Khan F, Kumar A, Kumar S, Arshad M. and growth inhibitory, anti-ovarian & anti-lung carcinoma effects of 1,5 diarylpenta-1,4-dien-3-one as synthetically modified curcumin analogue. Journal of Biomolecular Structure & Dynamics. 1-18. PMID 33955334 DOI: 10.1080/07391102.2021.1914166   
2021 Khatib TZ, Osborne A, Yang S, Ali Z, Jia W, Manyakin I, Hall K, Watt R, Widdowson PS, Martin KR. Receptor-ligand supplementation via a self-cleaving 2A peptide-based gene therapy promotes CNS axonal transport with functional recovery. Science Advances. 7. PMID 33789891 DOI: 10.1126/sciadv.abd2590   
2021 Jiang S, Iliopoulos-Tsoutsouvas C, Tong F, Brust CA, Keenan CM, Raghav JG, Hua T, Wu S, Ho JH, Wu Y, Grim TW, Zvonok N, Thakur GA, Liu ZJ, Sharkey KA, et al. Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists. Journal of Medicinal Chemistry. PMID 33761251 DOI: 10.1021/acs.jmedchem.0c02053   
2021 Lu JJ, Polgar WE, Mann A, Dasgupta P, Schulz S, Zaveri NT. Differential In vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G-protein and Beta-arrestin Signaling at the Human Nociceptin Opioid Receptor. Molecular Pharmacology. PMID 33958480 DOI: 10.1124/molpharm.120.000076   
2021 Wang D, Wang M, Sun P, Gao Q. Eplerenone inhibits oxidized low-density lipoprotein-induced proliferation and migration of vascular smooth muscle cells by downregulating GPER expression. Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University. PMID 33915037 DOI: 10.17219/acem/133484